Genfit SA EV - Enterprise Value 2011-2026 | GNFT

Annual EV - Enterprise Value Genfit SA

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	168 B	229 M	600 M	1.3 M	-84.9 M	23.4 M	13.8 M	15.9 M	15.1 M	16.7 M	24.6 M

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
168 B	-84.9 M	15.3 B

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Aptorum Group Limited APM	9.45 M	$ 0.82	-3.48 %	$ 4.47 M	China
Rigel Pharmaceuticals RIGL	679 M	$ 33.23	-4.03 %	$ 584 M	USA
Graybug Vision GRAY	8.71 M	-	-11.23 %	$ 9.65 M	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Ampio Pharmaceuticals AMPE	-1.05 M	-	-11.43 %	$ 502 K	USA
Apellis Pharmaceuticals APLS	3.01 B	$ 20.15	-2.68 %	$ 2.54 B	USA
AbCellera Biologics ABCL	1.22 B	$ 3.72	-2.75 %	$ 1.11 B	Canada
Athersys ATHX	-37.4 M	-	3.77 %	$ 22.4 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
AVEO Pharmaceuticals AVEO	86.9 M	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	8.95 B	$ 163.7	-1.61 %	$ 8.14 B	USA
BridgeBio Pharma BBIO	15.5 B	$ 64.66	-1.37 %	$ 12.4 B	USA
Brainstorm Cell Therapeutics BCLI	15.7 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
Burford Capital Limited BUR	3.22 B	$ 8.52	-2.46 %	$ 1.39 B	Britain
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
CymaBay Therapeutics CBAY	3.36 B	-	-	$ 3.45 B	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Avid Bioservices CDMO	661 M	-	-	$ 789 M	USA
Certara CERT	1.38 B	$ 7.16	1.49 %	$ 1.15 B	USA
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Checkpoint Therapeutics CKPT	174 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	-6.94 M	-	-16.75 %	$ 25.8 M	USA
Alpine Immune Sciences ALPN	363 M	-	-	$ 2.17 B	USA
Clovis Oncology CLVS	839 M	-	-7.23 %	$ 13 M	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Checkmate Pharmaceuticals CMPI	11.4 M	-	-	$ 231 M	USA
Capricor Therapeutics CAPR	177 M	$ 25.91	-3.56 %	$ 694 M	USA
Catalyst Pharmaceuticals CPRX	2.48 B	$ 24.0	0.5 %	$ 2.93 B	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
Codexis CDXS	354 M	$ 0.99	-3.28 %	$ 72.7 M	USA
Corvus Pharmaceuticals CRVS	88.4 M	$ 17.75	-0.79 %	$ 852 M	USA
CTI BioPharma Corp. CTIC	664 M	-	-	$ 1.2 B	USA
CohBar CWBR	410 K	-	-15.44 %	$ 2.2 M	USA
Cyclacel Pharmaceuticals CYCC	8.71 M	-	-5.98 %	$ 34.1 M	USA
Cyclacel Pharmaceuticals CYCCP	112 M	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	1.24 B	-	-	$ 2.18 B	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
Denali Therapeutics DNLI	3.01 B	$ 20.02	-4.67 %	$ 3.29 B	USA
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Eton Pharmaceuticals ETON	109 M	$ 17.54	-3.36 %	$ 450 M	USA
Entasis Therapeutics Holdings ETTX	51.1 M	-	-	$ 105 M	USA
Evofem Biosciences EVFM	75.8 M	-	7.55 %	$ 38.1 M	USA